$5B asset sale and 38% Fair Value gap: is this asset manager still running?

Alternative asset manager TPG has been identified as a potential $5 billion sale target for a healthcare software company in its portfolio, according to Reuters. InvestingPro members who entered the stock on July 1 last year have enjoyed a +11.64% return so far, placing it among the top performers on Investing.com's AI-powered list.

The stock's PEG ratio of 0.09 is particularly attractive, as it suggests strong growth potential relative to its valuation. However, the company's prospects could be impacted by upcoming earnings and the outcome of the potential sale, which could further influence market sentiment. With 10 downward estimates revised in the past 90 days, the consensus appears to be shifting lower ahead of the October 29 earnings report.

As is typical with the AI-powered model, TPG is held alongside other high-conviction picks, both in terms of price performance and underlying business fundamentals. For those considering entry, the wide gap between current price and fair value, combined with the robust fee earnings base, presents an intriguing opportunity.